DTIL: Precision BioSciences Market Capitalization

Precision BioSciences (DTIL) is systematically deploying its existing capital to drive innovation, with a portion of the costs offset by partner payments. This chart illustrates the asset's market value at 0.27, supporting a team of leading geneticists attracted by high bonuses and R&D budgets. The business relies on its proprietary ARCUS system, which creates a protected technological barrier and allows the company to avoid patent-related legal conflicts.

DTIL Precision BioSciences Inc.: Market Value in the range 07/04/2022 - 11/11/2026

Precision BioSciences Inc. - analytical breakdowns and key metrics (DTIL)

- stock price and consensus target price:

Stock Quotes Precision BioSciences, Inc.|DTIL - Analyst Forecast Prices

- market capitalization information:

Market Capitalization Precision BioSciences, Inc.|DTIL - Company Buyout Price

- issuer book value statistics:

Net Assets per Single Share Precision BioSciences|DTIL - Company Book Value|Market Capitalization to Book Value Ratio precisionbiosciences.com|DTIL - Total Business Assets

- company liabilities and liquidity data:

- business earnings and investment ratios data:

DTIL - Company Net Income|Projected Future Earnings Precision BioSciences|DTIL - Price to Earnings Ratio|Forward P/E Multiple Precision BioSciences, Inc.|DTIL - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precision BioSciences, Inc.|DTIL - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Precision BioSciences|DTIL - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months precisionbiosciences.com|DTIL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Precision BioSciences

Fundamental company analysis:DTIL (Precision BioSciences, Inc.)

Original product of Precision BioSciences Inc.

Market value dynamics serve as a key indicator of market confidence in assets. This metric is calculated as the product of the current share price and the total number of issued securities. By analyzing the aggregate value of a company's shares, an investor determines the business development vector in real time. For Precision BioSciences (DTIL), this trend reflects the capitalization of the unique ARCUS platform. High DNA editing precision provides the company with pricing power, supporting the overall business value.

Direct competitors